ATE425461T1 - Diagnose von hepatozellulärem karzinom - Google Patents

Diagnose von hepatozellulärem karzinom

Info

Publication number
ATE425461T1
ATE425461T1 AT03724724T AT03724724T ATE425461T1 AT E425461 T1 ATE425461 T1 AT E425461T1 AT 03724724 T AT03724724 T AT 03724724T AT 03724724 T AT03724724 T AT 03724724T AT E425461 T1 ATE425461 T1 AT E425461T1
Authority
AT
Austria
Prior art keywords
hepatocellular carcinoma
diagnosis
gpc3
subject
glypican
Prior art date
Application number
AT03724724T
Other languages
English (en)
Inventor
Jorge Filmus
Mariana Capurro
Original Assignee
Sunnybrook & Womens College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29584393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE425461(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sunnybrook & Womens College filed Critical Sunnybrook & Womens College
Application granted granted Critical
Publication of ATE425461T1 publication Critical patent/ATE425461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03724724T 2002-05-23 2003-05-22 Diagnose von hepatozellulärem karzinom ATE425461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38234002P 2002-05-23 2002-05-23

Publications (1)

Publication Number Publication Date
ATE425461T1 true ATE425461T1 (de) 2009-03-15

Family

ID=29584393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724724T ATE425461T1 (de) 2002-05-23 2003-05-22 Diagnose von hepatozellulärem karzinom

Country Status (17)

Country Link
US (1) US7883853B2 (de)
EP (1) EP1506406B1 (de)
JP (1) JP4455324B2 (de)
CN (1) CN100401068C (de)
AT (1) ATE425461T1 (de)
AU (1) AU2003229191B2 (de)
BR (1) BRPI0311233B8 (de)
CA (1) CA2482881C (de)
DE (1) DE60326567D1 (de)
ES (1) ES2324029T3 (de)
IL (1) IL164848A0 (de)
MX (1) MXPA04011132A (de)
NZ (1) NZ536521A (de)
PT (1) PT1506406E (de)
RU (1) RU2319969C2 (de)
WO (1) WO2003100429A2 (de)
ZA (1) ZA200410077B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022597A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体
WO2004022595A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha MRL/lprマウスを用いた抗体の作製
AU2002330482A1 (en) 2002-09-04 2004-03-29 Perseus Proteomics Inc. Method of diagnosing cancer by detecting gpc3
US7303914B2 (en) * 2003-01-30 2007-12-04 Hongyang Wang Monoclonal antibody against human hepatoma and use thereof
EP1671645A4 (de) * 2003-09-04 2007-07-25 Chugai Pharmaceutical Co Ltd Heilmittel und mittel zum nachweis von gallengangskrebs
WO2005085861A2 (en) * 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
JP4658926B2 (ja) 2004-04-28 2011-03-23 株式会社ペルセウスプロテオミクス 肝癌治療後の再発予測判定薬
PL1674111T3 (pl) 2004-07-09 2011-04-29 Chugai Pharmaceutical Co Ltd Przeciwciała anty-glipikan 3
KR20130103580A (ko) 2004-08-24 2013-09-23 추가이 세이야쿠 가부시키가이샤 항 글리피칸 3 항체를 이용한 어쥬번트 요법
JPWO2006038588A1 (ja) * 2004-10-05 2008-05-15 株式会社ペルセウスプロテオミクス 肝炎重篤化のモニター薬
JP4794457B2 (ja) * 2004-10-26 2011-10-19 中外製薬株式会社 糖鎖改変抗グリピカン３抗体
US20070087005A1 (en) 2005-10-14 2007-04-19 Lazar Gregory A Anti-glypican-3 antibody
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
US8663929B2 (en) * 2008-03-17 2014-03-04 University Of Miyazaki Method for detection of liver cancer cell using anti-glypican-3 antibody
CN101393217B (zh) * 2008-09-27 2012-05-30 中国人民解放军第二军医大学 一种原发性肝癌血清标志物的检测试剂盒
JP5439494B2 (ja) * 2008-10-21 2014-03-12 バイエル ヘルスケア エルエルシー 肝細胞癌と関連するシグネチャ遺伝子の同定
KR20100098324A (ko) * 2009-02-27 2010-09-06 포항공과대학교 산학협력단 Ｔｍ７ｓｆ３를 유효성분으로 함유하는 간암 진단용 조성물, 및 항 ｔｍ７ｓｆ３ 항체를 유효성분으로 함유하는 간암 진단 키트, 및 간암 예방 또는 치료용 약학 조성물
JP5704570B2 (ja) 2009-03-05 2015-04-22 独立行政法人産業技術総合研究所 肝内胆管がんの検出、判別方法
CN102180969B (zh) * 2011-01-30 2013-04-10 中国人民解放军军事医学科学院微生物流行病研究所 抗肝癌活性单克隆抗体及其应用
CN102183660A (zh) * 2011-03-09 2011-09-14 倪温慨 检测Glypican-3的时间分辨免疫荧光试剂盒
CN102353791A (zh) * 2011-06-30 2012-02-15 倪润洲 一种分离检测afp亚型的新方法
EP3557260B1 (de) 2012-12-21 2022-05-18 Chugai Seiyaku Kabushiki Kaisha Gpc3-gerichtetes arzneimittel, das einem patienten verabreicht wird, der auf die gpc3-gerichtete arzneimitteltherapie reagiert
TWI693073B (zh) 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
US20160000946A1 (en) * 2013-03-14 2016-01-07 The Board Of Trustees Of The Leland Stanford Junior University Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma
CN105452865A (zh) * 2013-08-06 2016-03-30 金弦起 小肝细胞癌和潜伏于肝硬化的肝细胞癌诊断用组合物
CN105849562B (zh) 2013-12-24 2019-08-16 中外制药株式会社 可溶性gpc3蛋白质的测定方法
SG11201609014TA (en) 2014-05-08 2016-12-29 Chugai Pharmaceutical Co Ltd Gpc3 -targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
RU2016150370A (ru) * 2014-05-22 2018-06-26 Дженентек, Инк. Антитела и иммуноконъюгаты против GPC3
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
KR101704533B1 (ko) * 2014-10-13 2017-02-09 경북대학교병원 간암 바이오마커로서의 ＥＲＲγ 및 이의 용도
EP3318879B1 (de) 2015-07-01 2020-10-21 Chugai Seiyaku Kabushiki Kaisha Verabreichung eines gegen gpc3 gerichteten therapeutikums an einen patienten mit bestätigter wirksamkeit des gegen gpc3 gerichteten therapeutikums
KR102777002B1 (ko) * 2015-08-03 2025-03-05 크라제 메디컬 씨오 리미티드 항글리피칸-3 항체 및 이의 응용
CN108738347B (zh) * 2016-03-10 2022-01-14 国立癌症研究中心 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
MX2018010546A (es) 2016-03-15 2019-02-20 Chugai Pharmaceutical Co Ltd Metodos de tratamiento de cancer que usan antagonistas de union al eje de muerte programada 1 (pd-1) y anticuerpos anti glipicano 3 (gpc3).
US20200216542A1 (en) 2017-09-20 2020-07-09 Chugai Seiyaku Kabushiki Kaisha Dosage regimen for combination therapy using pd-1 axis binding antagonists and gpc3 targeting agent
WO2023091909A1 (en) 2021-11-16 2023-05-25 Sotio Biotech Inc. Treatment of myxoid/round cell liposarcoma patients
CN114813266B (zh) * 2022-03-15 2025-08-22 中国人民解放军海军军医大学第三附属医院 血液样本中gpc-3复合物的富集、检测方法及应用
TW202511297A (zh) 2023-06-16 2025-03-16 大陸商信立泰（成都）生物技術有限公司 一種抗gpc3抗體或抗原結合片段及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU218175A (en) * 1974-09-12 1984-04-30 Schwartzhaupt Kg Process for total or individual determination of lactate dehydrogenase isoenzyme
US5171850A (en) * 1988-08-31 1992-12-15 The Ontario Cancer Institute Intestinal oncofetal gene
JP2946216B2 (ja) 1989-07-12 1999-09-06 武田薬品工業株式会社 新規ハイブリドーマ，モノクローナル抗体および用途
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
WO1999037764A2 (en) * 1998-01-27 1999-07-29 Vlaams Interuniversitair Instituut Voor Biotechnologie New members of the glypican gene family
CA2346264A1 (en) * 1998-10-16 2000-04-27 Regents Of The University Of California Glypicans for the detection and treatment of human carcinoma
ES2312586T3 (es) 2001-06-22 2009-03-01 Chugai Seiyaku Kabushiki Kaisha Inhibidor del crecimiento celular que contenga un anticuerpo anti-clipicano 3.

Also Published As

Publication number Publication date
AU2003229191B2 (en) 2009-07-30
BRPI0311233A2 (pt) 2016-06-28
IL164848A0 (en) 2005-12-18
EP1506406A2 (de) 2005-02-16
NZ536521A (en) 2006-04-28
MXPA04011132A (es) 2005-08-15
JP4455324B2 (ja) 2010-04-21
CA2482881A1 (en) 2003-12-04
CN100401068C (zh) 2008-07-09
BRPI0311233B1 (pt) 2019-08-13
RU2319969C2 (ru) 2008-03-20
US7883853B2 (en) 2011-02-08
WO2003100429A3 (en) 2004-02-19
HK1074251A1 (en) 2005-11-04
ZA200410077B (en) 2005-12-28
ES2324029T3 (es) 2009-07-29
BRPI0311233B8 (pt) 2021-07-27
US20050233392A1 (en) 2005-10-20
DE60326567D1 (de) 2009-04-23
JP2005526979A (ja) 2005-09-08
AU2003229191A1 (en) 2003-12-12
WO2003100429A2 (en) 2003-12-04
CA2482881C (en) 2016-11-08
PT1506406E (pt) 2009-06-03
CN1653336A (zh) 2005-08-10
RU2004136285A (ru) 2005-10-10
EP1506406B1 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
ATE425461T1 (de) Diagnose von hepatozellulärem karzinom
Farzin et al. Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
DK2073008T3 (da) Forbedrede immunoassayfremgangsmåder
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
SE0000538L (sv) Metoder och kit för analytdetektion mha proximitets-probning
JP2008530582A5 (de)
HRP20130127T1 (hr) Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega
WO2010011357A3 (en) Detection of prostate cancer using psa glycosylation patterns
EP1708745A4 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
WO2003087833A3 (en) A marker for measuring liver cirrhosis
ATE496301T1 (de) Verfahren zur krebsdiagnose mittels gpc3-nachweis
CA2808611A1 (en) Detecting circulating cartilage oligomeric matrix protein in liver cirrhosis
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DK0968421T3 (da) Diagnose af tidlig gastrisk cancer
ATE447713T1 (de) S100-proteine und -autoantikörper als serummarker für krebs
RU2011144835A (ru) Способы и композиции на основе белков для диагностики колоректальной аденокарциномы
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
CA2623653A1 (en) Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE394675T1 (de) Verfahren zum nachweis von brustkrebs
JP5133842B2 (ja) 癌が疑われる患者または癌患者由来の組織の癌部と非癌部との判別方法およびそれに用いる判別試薬
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties